News
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results